Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Rabinowitz

Showing results (61-70 of 109) with videos related to

Pageof 11
Sort By:
Schizophrenia Research|January 18, 2005
Association between functioning in adolescence prior to first admission for schizophrenia and affective disorders and patterns of hospitalizations thereafterJonathan Rabinowitz, Rachel Haim, Abraham Reichenberg, et al.
Psychiatry Research|February 19, 2002
Motivation to serve in the military influences vulnerability to future posttraumatic stress disorderZeev Kaplan, Mark Weiser, Abraham Reichenberg, et al.
Clinical Therapeutics|January 27, 2009
Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studiesRobin Emsley, Petrus Oosthuizen, Liezl Koen, et al.
International Clinical Psychopharmacology|October 16, 2008
Remission in patients with first-episode schizophrenia receiving assured antipsychotic medication: a study with risperidone long-acting injectionRobin Emsley, Petrus Oosthuizen, Liezl Koen, et al.
The Journal of Clinical Psychiatry|October 20, 2004
Behavioral and psychological symptoms in patients with dementia as a target for pharmacotherapy with risperidoneJonathan Rabinowitz, Ira R Katz, Peter Paul De Deyn, et al.
Journal of Clinical Psychopharmacology|March 18, 2008
Long-acting injectable risperidone in the treatment of subjects with recent-onset psychosis: a preliminary studyRobin Emsley, Rossella Medori, Liezl Koen, et al.
Schizophrenia Research|February 10, 2012
Negative symptoms have greater impact on functioning than positive symptoms in schizophrenia: analysis of CATIE dataJonathan Rabinowitz, Stephen Z Levine, George Garibaldi, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|November 16, 2005
Factor analysis of the Cohen-Mansfield Agitation Inventory in three large samples of nursing home patients with dementia and behavioral disturbanceJonathan Rabinowitz, Michael Davidson, Peter Paul De Deyn, et al.
Schizophrenia Research|March 24, 2004
The relationship of neuropsychological test performance with the PANSS in antipsychotic naïve, first-episode psychosis patientsKimberley P Good, Jonathan Rabinowitz, David Whitehorn, et al.
Dialogues in Clinical Neuroscience|March 20, 2025
Exploring novel therapeutic strategies: Could psychedelic perspectives offer promising solutions for Alzheimer's disease comorbidities?Michael Davidson, Gabriela-Dumitrita Stanciu, Jonathan Rabinowitz, et al.
Pageof 11

Showing results (61-70 of 109) with videos related to

Sort By:
Pageof 11
Schizophrenia Research|January 18, 2005
Association between functioning in adolescence prior to first admission for schizophrenia and affective disorders and patterns of hospitalizations thereafterJonathan Rabinowitz, Rachel Haim, Abraham Reichenberg, et al.
Psychiatry Research|February 19, 2002
Motivation to serve in the military influences vulnerability to future posttraumatic stress disorderZeev Kaplan, Mark Weiser, Abraham Reichenberg, et al.
Clinical Therapeutics|January 27, 2009
Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studiesRobin Emsley, Petrus Oosthuizen, Liezl Koen, et al.
International Clinical Psychopharmacology|October 16, 2008
Remission in patients with first-episode schizophrenia receiving assured antipsychotic medication: a study with risperidone long-acting injectionRobin Emsley, Petrus Oosthuizen, Liezl Koen, et al.
The Journal of Clinical Psychiatry|October 20, 2004
Behavioral and psychological symptoms in patients with dementia as a target for pharmacotherapy with risperidoneJonathan Rabinowitz, Ira R Katz, Peter Paul De Deyn, et al.
Journal of Clinical Psychopharmacology|March 18, 2008
Long-acting injectable risperidone in the treatment of subjects with recent-onset psychosis: a preliminary studyRobin Emsley, Rossella Medori, Liezl Koen, et al.
Schizophrenia Research|February 10, 2012
Negative symptoms have greater impact on functioning than positive symptoms in schizophrenia: analysis of CATIE dataJonathan Rabinowitz, Stephen Z Levine, George Garibaldi, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|November 16, 2005
Factor analysis of the Cohen-Mansfield Agitation Inventory in three large samples of nursing home patients with dementia and behavioral disturbanceJonathan Rabinowitz, Michael Davidson, Peter Paul De Deyn, et al.
Schizophrenia Research|March 24, 2004
The relationship of neuropsychological test performance with the PANSS in antipsychotic naïve, first-episode psychosis patientsKimberley P Good, Jonathan Rabinowitz, David Whitehorn, et al.
Dialogues in Clinical Neuroscience|March 20, 2025
Exploring novel therapeutic strategies: Could psychedelic perspectives offer promising solutions for Alzheimer's disease comorbidities?Michael Davidson, Gabriela-Dumitrita Stanciu, Jonathan Rabinowitz, et al.
Pageof 11